TY -的A2 -戴维斯,特里f . AU - Takasu Nobuyuki盟——松下,米娜PY - 2012 DA - 2012/05/10 TI -变化TSH-Stimulation抑制性抗体(TSBAb)和促甲状腺抗体(TSAb) / 10年34 TSBAb-Positive甲状腺功能减退患者和98年TSAb-Positive坟墓的甲状腺机能亢进患者:重新评价TSBAb和TSAb TSH-Receptor-Antibody (TRAb)阳性患者SP - 182176六世- 2012 AB -两个TRAbs: TSBAb TSAb。TSBAb导致甲状腺功能减退。TSAb原因坟墓的甲状腺机能亢进。TSBAb和TSAb块TSH-binding细胞TRAb,衡量TSH-binding抑制免疫球蛋白(TBII)。我们重新评估TSBAb TSAb。我们研究TSBAb、TSAb TBII超过10年34 TSBAb-positives甲状腺功能减退和98年TSAb-positives甲状腺机能亢进。一半的34 TSBAb-positives与甲状腺功能减退继续坚持积极TSBAb,继续有甲状腺功能减退,没有恢复甲状腺功能减退。10的98 TSAb-positives甲状腺机能亢进继续积极TSAb并继续甲状腺机能亢进。TSBAb消失了在15的34 TSBAb-positives与甲状腺功能减退。TSBAb的消失,甲状腺功能减退的康复在13日15例(87%)。 TSAb had disappeared in 73 of the 98 TSAb-positives with hyperthyroidism. With the disappearance of TSAb, remissions of hyperthyroidism were noted in 60 (82%) of the 73. Two of the 34 TSBAb-positives with hypothyroidism developed TSAb-positive Graves’ hyperthyroidism. Two of the 98 TSAb-positive Graves’ patients with hyperthyroidism developed TSBAb-positive hypothyroidism. TSBAb and TSAb are TRAbs. TSBAb-hypothyroidism and TSAb-hyperthyroidism may be two aspects of one disease (TRAb disease). Two forms of autoimmune thyroiditis: atrophic and goitrous. We followed 34 TSBAb-positive patients with hypothyroidism (24 atrophic and 10 goitrous) over 10 years. All of the 10 TSBAb-positive goitrous patients recovered from hypothyroidism and 19 (79%) of the 24 TSBAb-positive atrophic patients continued to have hypothyroidism. SN - 2090-8067 UR - https://doi.org/10.1155/2012/182176 DO - 10.1155/2012/182176 JF - Journal of Thyroid Research PB - Hindawi Publishing Corporation KW - ER -